Sign up Australia
Proactive Investors - Run By Investors For Investors

Paragon Care has a new asset in its sights

Paragon has been acquiring businesses in the healthcare sector.
Paragon Care has a new asset in its sights
The company's shares are in pre-open

Paragon Care Ltd (ASX:PGC) is back on the acquisition trail, with the ASX granting the company a trading halt this morning pending its next bolt on.

Earlier in the year Paragon outlined nine acquisition opportunities in the healthcare sector during the company's $69.8 million capital raising.

Seven of these have been completed so far.

Paragon is also set for a busy June quarter, as historically over a third of the year’s business has normally been transacted during this period.

The company is a provider of medical equipment, devices and consumables for the Australian and New Zealand healthcare market.

The halt will remain in place until the opening of trade on Friday 8 June 2018, or earlier if an announcement is made to the market.

View full PGC profile View Profile

Paragon Care Ltd Timeline

Newswire
August 14 2015
Newswire
September 19 2014
Newswire
May 17 2013
Newswire
January 29 2013

Related Articles

blood
April 01 2018
The company is in the process of raising £5mln, with a possible further £1mln through a share issue at 52.5p
Summit
January 26 2018
Interim results for a study on ezutromid revealed a “statistically significant and meaningful” reduction in muscle damage, the company said
t-cell
April 04 2018
£1,000 invested at float two years ago would now be worth just north of £3,500

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use